As of January 1, 2018 the State of Connecticut mandates controlled substance prescriptions be sent electronically. To combat prescription drug abuse, Complete HealthCare Solutions, Inc. recommends that all prescriptions be sent electronically.
Award-winning stand-alone legend drug e-prescribing solution, with integrated medication history, formulary, drug interaction and medication adherence functionality.
Add-on functionality for Rcopia, the industry’s first DEA-approved two-factor authentication system for controlled substance e-prescribing.
Native within Rcopia, cutting-edge clinical, behavioral and financial support functionality to increase medication adherence monitoring and patient disease self-management.
Includes patient worklist, document management, medication list, allergies, problem lists, patient education, patient letters, refill request management, and universal connectivity bridge to your practice management system.
Lytec and Medisoft PM's integration is included.
Easy to use Drummond certified to meet Meaningful Use and MIPS.
Designed by Lytec and Medisoft Users for Lytec and Medisoft Users. Put the full power of your PM data to work by simply adding UnifiMD to your Lytec or Medisoft System.
In response to the recent CT law requiring providers to utilize an electronic prescription solution Complete HealthCare Solutions, Inc. is offering a 20% savings on each of the the UnifiMD Solutions.
Prescribers in Connecticut must electronically prescribe controlled substances by January 1, 2018. The law proposed by Governor Dannel Malloy was passed in June 2017 in an effort to combat opioid abuse and addiction.
The Connecticut Prescription Monitoring and Reporting System (CPMRS) collects prescription data for all Schedule II through Schedule V drugs dispensed in Connecticut daily. Prescribers who have a Connecticut Controlled Substance (CSP) Registration issued by the State of Connecticut, Department of Consumer Protection, are required to register as a user with the CPMRS. Prescribers are required to review a patient’s record in the CPMRS at least every 90 days if they prescribe greater than a 72-hour supply of any controlled substance. However, if they prescribe greater than a 72-hour supply of any Schedule V nonnarcotic controlled substance, prescribers are required to review the patient's record in the CPMRS at least annually.